Sagent Pharmaceuticals (SGNT) says that due to the current shortage of Sodium Bicarbonate...

|About: Sagent Pharmaceuticals (SGNT)|By:, SA News Editor

Sagent Pharmaceuticals (SGNT) says that due to the current shortage of Sodium Bicarbonate Injection in the U.S. market, it's cooperating with the FDA to initiate the temporary importation of a non-FDA approved 8.4% Sodium Bicarbonate Injection from Australian manufacturer Phebra Pty.